Endogenous Hydrogen Sulfide-Triggered MOF-based Nanoenzyme for Synergic Cancer Therapy.

Yite Li,Junli Zhou,Lei Wang,Zhigang Xie
DOI: https://doi.org/10.1021/acsami.0c08659
2020-06-09
Abstract:The developing nanoparticle therapeutic agents triggered by tumor microenvironment (TME) are a feasible strategy for the substantial elevation of accuracy of diagnosis and the reduction of side effects in cancer treatments. Dysregulated H2S production from the enzyme system of overexpressed cystathionine β-synthase (CBS) has long been considered to act as an autocrine and paracrine factor for the tumor growth and proliferation of colon cancer. Herein, for the first time, an endogenous H2S-activated Cu-MOF (HKUST-1) nanoenzyme have been demonstrated to synergistically mediate H2S-activated near-infrared (NIR) photothermal therapy (PTT) and chemodynamic therapy (CDT) in the effective treatment of colon cancer. This endogenous biomarker-triggered "turn-on" strategy to generate therapeutic agents in situ could largely simplify the constitution of nanomedicine by avoiding the cargo introduction, and thus supply great promises for the precise treatments of colon cancer.
Materials Science
What problem does this paper attempt to address?